Compare KMDA & HQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KMDA | HQ |
|---|---|---|
| Founded | 1990 | 2018 |
| Country | Israel | Singapore |
| Employees | N/A | 44 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 460.3M | 542.1M |
| IPO Year | 2013 | N/A |
| Metric | KMDA | HQ |
|---|---|---|
| Price | $7.18 | $10.65 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | 55.4K | ★ 255.6K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.08% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.94 | N/A |
| Revenue Next Year | $9.84 | N/A |
| P/E Ratio | $24.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.50 | $8.29 |
| 52 Week High | $9.35 | $14.65 |
| Indicator | KMDA | HQ |
|---|---|---|
| Relative Strength Index (RSI) | 31.34 | 45.04 |
| Support Level | $6.57 | $9.38 |
| Resistance Level | $7.41 | $13.67 |
| Average True Range (ATR) | 0.14 | 1.63 |
| MACD | -0.05 | -0.24 |
| Stochastic Oscillator | 12.95 | 19.43 |
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Horizon Quantum Holdings Ltd is building software infrastructure to make quantum computers accessible to commercial enterprises and hardware providers. By bridging the gap between hardware and applications, the company seeks to equip developers, researchers, and enterprises with the quantum software infrastructure needed to solve real-world problems. The company is developing tools that can automatically accelerate code written for conventional computers on quantum computers.